@misc{indiciaeeaba43cbdfc1,
  title = {Pharmacological SOS1 inhibitor BI-3406 demonstrates in vivo anti-tumor activity comparable to SOS1 genetic ablation in KRAS mutant tumors},
  author = {BALTANAS, F. C. and Kramer-Drauberg, M. and Garcia-Navas, R. and Patrucco, E. and Petrini, E. and Arnhof, H. and Olarte-San Juan, A. and Rodriguez-Ramos, P. and Borrajo, J. and Calzada, N. and Castellano, E. and Mair, B. and Kostyrko, K. and Hofmann, M. H. and Ambrogio, C. and Santos, E.},
  year = {2024},
  doi = {10.1101/2024.09.18.613686},
  url = {https://www.biorxiv.org/content/10.1101/2024.09.18.613686v1},
  note = {Source identifier: 10.1101/2024.09.18.613686}
}